GlassScriptPhysician profile
Shawn Tai
NPI 1306005798
$9,129.75
in general payments reported to CMS, 2019-2025
65 companies · $2,417 in 2025
The $2,417 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $98.37 · 2021: $825 · 2022: $1,384 · 2023: $1,748 · 2024: $1,963 · 2025: $2,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,916 · Long Term Medical Supply Or Device Loan: $167 · Education: $44.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,916.35 |
| Long Term Medical Supply Or Device Loan | $166.66 |
| Education | $44.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,332.98 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $697.91 | 2022-2025 | Imjudo, Imfinzi, Enhertu |
| Pfizer INC. | $607.84 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $476.19 | 2019-2025 | Opdivo |
| Glaxosmithkline, LLC. | $464.01 | 2021-2025 | Jemperli, Ojjaara, Zejula |
| Merck Sharp & Dohme LLC | $377.76 | 2019-2025 | Keytruda, Welireg, Keytruda Qlex |
| Janssen Biotech, INC. | $334.55 | 2019-2025 | Erleada, Tecvayli, Imbruvica |
| Abbvie INC. | $311.19 | 2023-2025 | Venclexta |
| Bayer Healthcare Pharmaceuticals INC. | $289.92 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $281.85 | 2019-2025 | Libtayo, Lynozyfic |
| Incyte Corporation | $243.23 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Myriad Genetic Laboratories, INC. | $195.63 | 2021-2025 | Myrisk |
| Celgene Corporation | $188.56 | 2019-2025 | Reblozyl, Opdualag |
| Array Biopharma INC | $184.23 | 2021-2025 | Mektovi, Braftovi, Xalkori |
| Genentech USA, INC. | $181.72 | 2019-2025 | Tecentriq, Tecentriq Hybreza, Polivy |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $176.18 | 2019-2025 | Xtandi, Xospata |
| Amgen INC. | $167.88 | 2020-2023 | Lumakras, Xgeva, Nplate |
| Takeda Pharmaceuticals U.S.A., INC. | $160.55 | 2021-2025 | Ninlaro, Iclusig, Gammagard |
| Stemline Therapeutics INC. | $150.11 | 2023-2025 | Orserdu |
| Pharmacyclics LLC, An Abbvie Company | $138.01 | 2020-2023 | Epkinly, Imbruvica |
| Sobi, INC | $121.69 | 2023-2025 | |
| Genzyme Corporation | $115.06 | 2019-2024 | |
| Eisai INC. | $111.62 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $101.79 | 2019-2023 | Tavalisse, Rezlidhia |
| Alexion Pharmaceuticals, INC. | $98.05 | 2024-2025 | Ultomiris |
| Blueprint Medicines Corporation | $92.43 | 2021-2025 | Ayvakit |
| Karyopharm Therapeutics INC. | $89.70 | 2021-2024 | Xpovio |
| Exelixis INC. | $87.19 | 2019-2025 | Cabometyx |
| Emd Serono, INC. | $85.80 | 2022-2025 | Bavencio |
| Lilly USA, LLC | $82.21 | 2021-2024 | Verzenio, Jaypirca, Retevmo |
| Cti Biopharma Corp. | $81.06 | 2022-2023 | Vonjo |
| Adc Therapeutics America, INC. | $74.91 | 2022-2024 | |
| Tempus Ai, INC | $71.42 | 2024-2025 | Xt Cdx |
| Dendreon Pharmaceuticals LLC | $70.13 | 2022-2025 | Provenge |
| Pharmaessentia USA Corporation | $66.29 | 2022-2025 | Besremi |
| Kyowa Kirin, INC. | $64.11 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $60.03 | 2024-2025 | |
| Taiho Oncology, INC. | $56.83 | 2019-2022 | |
| Mirati Therapeutics, INC. | $43.11 | 2024 | Krazati |
| Seagen INC. | $41.72 | 2022-2023 | Tukysa |
| Daiichi Sankyo INC. | $39.93 | 2020-2021 | |
| Epizyme, INC. | $35.58 | 2022 | |
| Morphosys, US INC. | $30.91 | 2022-2023 | Monjuvi |
| Immunocore Limited | $29.24 | 2025 | Kimmtrak |
| Tolmar, INC. | $24.59 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $24.59 | 2025 | Rubraca |
| Kite Pharma, INC. | $24.27 | 2021 | |
| Syndax Pharmaceuticals, INC. | $24.26 | 2025 | |
| Servier Pharmaceuticals LLC | $24.17 | 2025 | |
| Aveo Pharmaceuticals, INC. | $24.05 | 2025 | |
| Eagle Pharmaceuticals, INC. | $22.72 | 2020 | |
| Pharmacosmos Therapeutics INC. | $22.64 | 2025 | Monoferric |
| Tersera Therapeutics LLC | $22.15 | 2019 | |
| Novocure INC. | $21.47 | 2019 | |
| Geron Corporation | $21.36 | 2025 | Rytelo |
| Ipsen Biopharmaceuticals, INC | $19.65 | 2025 | Onivyde |
| Amneal Pharmaceuticals LLC | $19.45 | 2024 | Alymsys |
| Beone Medicines USA, INC. | $19.20 | 2025 | Brukinsa |
| Sumitomo Pharma America, INC. | $18.27 | 2023 | Orgovyx |
| Iovance Biotherapeutics, INC. | $15.78 | 2025 | Amtagvi |
| Gilead Sciences, INC. | $15.10 | 2023 | Trodelvy |
| Myovant Sciences INC. | $14.74 | 2021 | |
| Acrotech Biopharma INC. | $14.36 | 2025 | Beleodaq |
| Janssen Pharmaceuticals, INC | $13.13 | 2021 | |
| Puma Biotechnology, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Tai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.